Abstract: While improvements made in the field of cancer therapy allow high survival rates, gonadotoxicity of chemo-and radiotherapy can lead to infertility in male and female pre-and postpubertal patients. Clinical options to preserve fertility before starting gonadotoxic therapies by cryopreserving sperm or oocytes for future use with assisted reproductive technology (ART) are now applied worldwide. Cryopreservation of pre-and postpubertal ovarian tissue containing primordial follicles, though still considered experimental, has already led to the birth of healthy babies after autotransplantation and is performed in an increasing number of centers. For prepubertal boys who do not produce gametes ready for fertilization, cryopreservation of immature testicular tissue (ITT) containing spermatogonial stem cells may be proposed as an experimental strategy with the aim of restoring fertility. Based on achievements in nonhuman primates, autotransplantation of ITT or testicular cell suspensions appears promising to restore fertility of young cancer survivors. So far, whether in two-or three-dimensional culture systems, in vitro maturation of immature male and female gonadal cells or tissue has not demonstrated a capacity to produce safe gametes for ART. Recently, primordial germ cells have been generated from embryonic and induced pluripotent stem cells, but further investigations regarding efficiency and safety are needed. Transplantation of mesenchymal stem cells to improve the vascularization of gonadal tissue grafts, increase the colonization of transplanted cells, and restore the damaged somatic compartment could overcome the current limitations encountered with transplantation.
Introduction
Some years ago, fertility preservation (FP) emerged as a treatment aiming to preserve future reproductive capacity of individuals facing therapies that could potentially affect their gonads, the majority being patients diagnosed with cancer. 1 Indeed, chemo-and radiotherapy are associated with gonadotoxicity in both males and females. 2 Other health conditions can motivate FP, such as genetic abnormalities or autoimmune diseases. 3, 4 For adult men or adolescents, cryopreservation of ejaculated or surgically retrieved sperm is routinely proposed before gonadotoxic therapies, while for prepubertal boys, cryopreservation of a testicular biopsy containing spermatogonial stem cells (SSCs) is now ethically accepted as the only way to offer an FP strategy from the perspective of future developments allowing parenthood. 5 Several studies have broached the feasibility of cryopreservation of immature testicular tissue (ITT), [6] [7] [8] [9] [10] [11] [12] [13] and some teams have developed protocols for its clinical implementation. 7, 10, 12, 14 Although still at the research stage, autotransplantation and in vitro maturation (IVM) of ITT or SSCs have been considered to restore fertility from cryopreserved ITT. Restoration of the damaged SSC niche with mesenchymal stem cells (MSCs) was also recently proposed to enhance or restore endogenous spermatogenesis. 15 For women, cryopreservation of oocytes or embryos is the most common way to preserve fertility. 16, 17 However, while oocyte cryopreservation may also be proposed to adolescent girls, it cannot be proposed before puberty or to adult women requiring urgent therapy. Cryopreservation of ovarian tissue containing primordial follicles may be proposed with an aim to transplant it back to the patient after cure, a technique that has already proved its efficacy with births of healthy babies. 18 However, early postgrafting follicle loss has motivated researchers to improve the procedure, and potential neoplastic tissue contamination (making it unsafe for transplantation) increases the need to find alternative FP methods. While SSCs, originating from differentiation of gonocytes after birth, continuously divide asymmetrically to give rise to new SSCs and differentiating germ cells, 19 embryonic oogonia enter a resting stage (prophase of meiosis I) and undergo final maturation only at the onset of puberty, thus constituting a fixed ovarian reserve that decreases during a lifetime. 20 This classical scheme was questioned during the last decade with the discovery of potential female germ-line stem cells (FGSCs) in the ovary, opening a debate that is not over yet. 21 In this review, we present current FP approaches for male and female patients facing gonadotoxic therapies and methods that could be applied to improve their impaired fertility using cryostored gonadal material and other sources of stem cells (SCs) that may enhance in vitro and vivo germ-cell differentiation or develop into gametes.
Materials and methods Methods
A search was performed on PubMed using the following combination of terms without time limitation: ([fertility] AND [restoration OR preservation]) AND (stem cell OR germline stem cell OR oogonia OR spermatogonial stem cell OR spermatogonia). Articles in languages other than English, guidelines, reviews, and scientific video protocols were excluded. Figure 1 shows a flowchart describing the selection of papers. From the 458 results, 60 focusing on the main topic were selected and 136 added for their relevance to understanding and discussion.
Results

Literature search
SSCs to restore fertility in the male
SSCs are known as a subpopulation of spermatogonia localized at the basement membrane of seminiferous tubules (STs) and estimated to represent 0.03% of germ cells in the adult mouse. 22 These diploid SCs are able both to self-renew and give rise to differentiated haploid cells at the end of the spermatogenic process. 19 Due to the smallness of testicular biopsies taken for cryopreservation in prepubertal boys, the scarcity of SSCs in the testes, 23 the low efficiency of the transplantation process observed in mice and nonhuman primates, 24, 25 and the low proportion of human haploid germ cells generated with IVM, 26 amplification of SSCs is an essential step for fertility restoration.
SSC propagation
The development of SSC propagation-culture systems has mainly been achieved through studies in rodents. In 2003, Kanatsu-Shinohara et al reported the first long-term amplification of murine SSCs for >5 months in a specific medium containing glial cell line-derived neurotrophic factor (GDNF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and leukemia inhibitory factor (LIF), which were considered as essential for SSC culture. 27 Indeed, both in vivo and vitro studies brought evidence that GDNF plays a pivotal role in SSC selfrenewal. 28, 29 Moreover, bFGF was shown to potentiate the effect of GDNF, as addition of bFGF to culture media containing GDNF increased the number of SSC colonies compared to culture without bFGF, 28 while LIF and EGF were shown to act on SSC colony formation 30 and diameter, 31 respectively. Subsequently, several teams attempted to find a culture system of dissociated testicular cell suspensions (TCSs) able to propagate human SSCs in vitro (Table 1) . 32 Together, these results point to the need to identify the best method to propagate SSCs most efficiently. Recently, Bhang et al discovered that human endothelial TCs secreted GDNF, bFGF, stromal cell-derived factor-1 (SDF-1), macrophage inflammatory protein 2, and insulin-like growth factor-binding protein 2 and could support SSC growth for at least 150 days. 51 It also appeared that cells with MSC characteristics were able to support spermatogonia in vitro. Indeed, Smith et al showed that a THY1 + fraction isolated from TCSs was of mesenchymal origin and could support SSEA-4 + SSC growth, while mouse embryonic fibroblasts and human placental and fetal testicular stromal cells could not. 59 Interestingly, human umbilical perivascular cells (HUPVCs), which are also of mesenchymal origin and share common properties with somatic TCs (LIF, bFGF, and BMP4 secretion as well as expression of testicular extracellular matrix markers) also supported germ-cell proliferation and survival. 66 
SSC transplantation
Spermatogenesis restoration can be achieved both by injection of isolated SSCs into germ-cell-depleted testes and transplantation of an ITT piece where SSCs remain within their intact niche or original microenvironment. 67 
Transplantation of isolated SSCs
The first success using SSC transplantation to restore fertility was achieved in mice by Brinster and Avarbock who reported complete spermatogenesis and offspring after SSC injection into STs of busulfan-sterilized mice. 68 In order to evaluate the capacity of transplanted SSCs to colonize their niche, recipient mice were injected intraperitoneally with busulfan inducing germ-cell depletion and improving donor SSC colonization ( Figure 2 ). Recently, a higher proportion of donor-derived offspring generation was reported when busulfan was injected directly into testes. 69 The power of the technique for FP was further demonstrated with offspring in several species, including rats, goats, chickens, and sheep, and embryo development in nonhuman primates. [70] [71] [72] [73] [74] The spermatogenic process has also been completed in bovines, pigs, and dogs, but sperm functionality was not evaluated. [75] [76] [77] In addition, cryopreservation of mouse, rat, rabbit, and baboon SSCs did not affect their viability neither their ability to colonize mouse STs, 78 and culture of thawed mouse [78] [79] [80] and rat 78 SSCs resulted in spermatogenesis after transplantation. The safety of the procedure was studied in mice, and although differences in histone acetylation of germ cells SSCs from group 1 died after 2 weeks in culture, while SSCs from group 2 proliferated for 150 days and were able to migrate along the basement membrane of STs following xenotransplantation to nude mice
Abbreviations: ALP, alkaline phosphatase; bFGF, basic fibroblast growth factor; CD, cluster of differentiation; CDH1, cadherin-1; DAZL, deleted in azoospermia like; DDX4, DEAD-box helicase 4; DP, differential plating; DSA, datura stramonium agglutinin; FACS, fluorescence-activated cell sorting; FGFR3, fibroblast growth factor receptor 3; GFRα1, GDNF family receptor alpha 1; GPR125, G-protein coupled receptor 125; GSCs, germ-line stem cell; ID4, inhibitor of DNA binding 4; IF, immunofluorescence; IHC, immunohistochemistry; ITGα6, integrin subunit alpha 6; ITGβ1, integrin subunit beta 1; iPS-EC, iPS-derived endothelial cell; ITT, immature testicular tissue; LIN28, LIN28 homolog A; MACS, magnetic activated cell sorting; MAGEA4, MAGE family member a4; OCT4, octamer-binding transcription factor 4; NA, not available; PIWIL2, Piwi like RNA-mediated gene silencing 2; PLZF, promyelocytic leukaemia zinc finger protein;
RET, ret proto-oncogene; SALL4, sal-like protein 4; SSC, spermatogonial stem cell; SSEA-4, stage-specific embryonic antigen 4; STRA8, stimulated by retinoic acid 8; SOX2, SRY (sex-determining region Y)-box 2; TCS, testicular cell suspension; TESE, testicular sperm extraction; UCHL1, ubiquitin C-terminal hydrolase L1; UTF1, undifferentiated embryonic cell transcription factor 1.
were observed, 81 no modifications in the genomes of offspring were found. 82 In addition, propagation of moue SSCs before transplantation did not increase the incidence of cancer or decrease the survival of mice that had undergone SSC transplantation. 83 In view of these encouraging results, SSC transplantation is considered a potential fertility-restoration method for future clinical application (Figure 3) . Using cadaver testes, ultrasound-guided injection in the rete testis has been determined as the best technique for cell transplantation in larger testes. 84, 85 So far, only one report has described autotransplantation of cryopreserved human TCSs in patients cured of non-Hodgkin's lymphoma, but no follow-up was published. 86 An important clinical concern is the risk of cancer-cell contamination of the TCSs to be transplanted, since transplantation of only 20 leukemic cells in rats has resulted in cancer relapse. 87 To address this issue, several teams searched for extracellular markers allowing separation of human SSCs from cancer cells but completely safe purification is not yet possible using cell-sorting techniques. 56, 58, [88] [89] [90] However, the culture protocol developed by Sadri-Ardekani et al allowed elimination of malignant cells added to the cell suspension, and may represent a good alternative to sorting approaches. 46 Furthermore, long-term culture of human SSCs did not show increased chromosomal abnormalities in another study, but methylation assays demonstrated demethylation of three paternally imprinted genes and increased methylation of two maternally imprinted genes after 50 days. 44 The impact of such modifications on offspring are not known and difficult to predict. While it is possible that once transplanted, SSCs and generated spermatozoa could retrieve a normal methylation pattern, it was also hypothesized that cultured and transplanted human SSCs might be unable to enter meiosis or lead to embryos that will degenerate because of their inability to pass cellular checkpoints. 
Transplantation of ITT (SSCs within their niche)
The main aim of tissue transplantation rather than cell transplantation is that cellular interactions within the SC niche are preserved, which is important for germ-cell proliferation and maturation. 91 However, as grafting of thawed ITT contaminated by leukemic cells has resulted in development of generalized leukemia in rats, 92 this technique must be restricted to nonhematological or nonmetastasizing cancers and to benign disorders requiring gonadotoxic therapies. Xenotransplantation of mouse, rabbit, porcine, Japanese quail, and cynomolgus monkey ITT to nude mice leads to offspring generated with sperm retrieved from the in vivo matured grafts. [93] [94] [95] [96] With regard to human ITT, experiments have shown a blockade of differentiation at the pachytene spermatocyte stage, probably due to the phylogenetic distance between the mice and humans. 11, 97 Different grafting sites have been put forward. Intratesticular grafting was proposed as a grafting site, assuming that it could be advantageous to transplant the tissue into its natural environment with high testosterone levels and that breeches created in the parenchyma to insert the graft favor donor SSC colonization, although human germ-cell differentiation was still arrested at the spermatocyte stage. 98, 99 For obvious microbiological reasons, xenotransplantation cannot be considered for clinical purposes. Autologous transplantation of ITT, however, suppresses such animal contamination risks (Figure 3) . Initially, ectopic transplantation in monkeys showed meiotic arrest. 100,101 Importantly, Jahnukainen et al reported sperm maturation after autologous grafting of cryopreserved ITT into the scrota of busulfan-treated monkeys, suggesting that the technique could be translated to the clinic. 13 Very recently, this potential was further supported by successful production of sperm and generation of a healthy baby following autologous transplantation of rhesus macaque ITT. Interestingly, offspring were obtained with sperm recovered from a scrotal graft, but the authors Figure 3 Fertility preservation in males. Notes: As they do not produce sperm, prepubertal boys can benefit from cryopreservation of a testicular tissue biopsy that could be used in the future for: 1) SSC isolation and propagation, with a view to restoring fertility of the patient by transplantation into own STs or for IVM to produce competent sperm for ART; 2) IVM in organotypic or microfluidic culture systems, with the aim to obtain sperm usable in ART; and 3) transplantation back into the patient to induce maturation and generation of spermatozoa that can be recovered and used for ART. did not detect any differences in the percentage of STs displaying complete spermatogenesis between grafting sites (back skin and scrotum). 102 
In vitro maturation of SSCs
The aim of IVM is to promote in vitro differentiation of SSCs into spermatozoa able to fertilize an oocyte during an assistedreproductive technology (ART) procedure (Figure 3) . This strategy presents an advantage over transplantation to avoid the risk of disease relapse in cases of tissue contamination with neoplastic cells.
IVM of dissociated TCs
In mammals, in vitro differentiation of germ cells seems to require a 3D rather than 2D environment considering promising results obtained in monkeys 103 and humans 104 using soft-agar and methylcellulose-culture systems. With regard to human SSCs, postmeiotic cells in 2 of 6 immature TCSs cultured in a methylcellulose system and spermatozoon-like cells (based on mitochondria localization) in 1 out of 6 cultured TCSs were obtained in one study. 104 In another, spermatozoon-like cells were also generated using chitosan cylinders to culture dissociated STs from adult transsexual patients after hormonal therapy. 105 However, whether differentiated germ cells originate from SSCs or spermatogonia already committed to differentiation remains unknown. Recently, the fertilization capacity of round spermatids obtained after IVM of human GPR125 + spermatogonia was demonstrated using mouse oocytes with subsequent 8-cell stage embryo development. 106 
IVM of intact ITT (SSCs within their niche)
Organotypic culture of ITT allows preservation of cell interactions inside the niche and leads to germ-cell differentiation up to the haploid stage in rodents, with generation of offspring in mice. 107, 108 Recently, a long-term organotypic culture of human ITT able to preserve ST integrity and Leydig cell functionality and achieve Sertoli cell maturation with partial establishment of the blood-testicular barrier 109, 110 eventually led to the generation of haploid germ cells. 26 As a decrease in spermatogonial numbers and only a few postmeiotic germ cells were observed, the next hurdles to overcome before clinical translation are enhancing the efficiency of the technique and demonstrating the fertilizing capacity and genetic integrity of in vitro matured cells. Recently, Ogawa developed a microfluidic culture system allowing growth of mice ITT for up to 6 months and resulting in higher spermatogenesis efficiency compared to standard organotypic culture, which could eventually address issues that have been encountered with human tissue. 111 In this well-designed system, a porous polydimethylsiloxane (PDMS) membrane separated mouse ITT from flowing medium, allowing physiological exchanges between the chamber and the media as secreted molecules were maintained for a longer period in the chamber compared to free diffusion occurring in the classical organotypic culture system. Moreover, diffusion of oxygen through the PDMS membrane resulted in a reduction in oxygen toxicity compared to direct exposure. Later, the same group modified their culture system by suppressing the need for a pump, making its use simpler.
112,113
Using other SCs to restore male fertility 116 However, ESCs are genetically unrelated to patients, and their procurement is complicated by ethical issues on embryo destruction. Researchers thus focused on human-induced pluripotent stem cells (hiPSCs) derived from skin and cord-blood cells that were also differentiated in haploid germ cells, though with incomplete imprinting reestablishment ( Figure 3) . 117 Other teams derived male germ cells from hESCs or hiPSCs, but most of the differentiated cells remained at early stages, suggesting low efficiency of the process. [118] [119] [120] [121] [122] [123] [124] Lower efficiency has been observed for differentiation of skin-derived iPSCs into haploid cells for patients with azoospermic factor C deletion. 125 One group suggested the existence of another source of SCs they called "very small embryonic stem cells (VSELs)" residing in the testes, where they undergo asymmetric divisions, giving rise to A (dark) spermatogonia that proliferate and differentiate into A (pale) and B spermatogonia. 126 In humans, the potential of these cells to differentiate in vitro has never been investigated, although based on the nuclear expression of OCT4 and cytoplasmic expression of SSEA-4 and STELLA, their presence was suggested in testes of childhood cancer survivors aged 23 to 35 years. 127 However, a large part of the scientific community is not convinced about the existence of VSELs, and researches refuted their SC properties. 128, 129 While researchers are currently actively working on these approaches, it is important to note that besides a high degree of uncertainty regarding functionality and safety, the fertilizing capacity of human in vitro differentiated ESCs and iPSCs has not been evaluated.
Using SCs to rescue damaged SSC niches
From the perspective of future clinical application, the question of whether SSC transplantation in a chemotherapy/radiotherapy-damaged niche may restore fertility arises, as Sertoli and Leydig cell defects have both been reported after gonadotoxic therapy. 130 Figure 3 ). In this regard, MSCs can be considered deal candidates, since several studies have suggested that male fertility can be improved, thanks to their paracrine secretions (Table 2) . Indeed, umbilical cord-derived MSCs secrete factors known to play an important role in spermatogenesis such as granulocyte-colony stimulating factor, vascular endothelial growth factor, and GDNF, 134 as well as enhanced expression of meiotic genes, when injected into busulfan-sterilized mice. 135 Also, SDF-1 is another MSC-secreted factor 136 involved in SSC migration and homing, as deletion of the CXCR4 in mouse germ cells reduces SSC homing, but not their proliferation or survival. 137 It can thus be hypothesized that cotransplantation of MSCs with SSCs could improve colonization efficiency, previously reported as low. 24 Moreover, in one study HUPVCs shared molecular properties with adult somatic TCs, notably secretion of LIF, bFGF, and BMP4, known as regulators of spermatogenesis, and their transplantation promoted ST regeneration after exposure to mono-2-ethylhexyl phthalate, while all STs were damaged in controls. 66 The authors assumed that the mesenchymal origin shared by Sertoli cells and HUPVCs explained the common properties of the two cell types and their ability to support SSCs. In the same way, adipose-derived stem cell (ASC) transplantation in efferent ducts of busulfansterilized hamsters allowed resumption of spermatogenesis. 138 SCs to restore fertility in the female
Current evidence of SCs in the ovary
The conventional view that mammalian ovaries do not produce oocytes after birth has been challenged in recent decades with the discovery of FGSCs in ovaries of juvenile and adult mice. 21 Mathematical calculations demonstrated that the rate of follicular atresia did not coincide with the age at which mice exhausted their follicular reserve, suggesting that neo-oogenesis occurred in ovarian tissue to reestablish the follicle pool and ensure reproductive potential during adulthood. 21 Indeed, it was demonstrated that FGSCs isolated from mice ovaries maintained proliferative activity in vitro and led to offspring after transplantation to sterile mice. 21, [141] [142] [143] [144] [145] Their presence was also demonstrated in prepubertal rat 146 and pig 147 and adult pig 148 and human 149 ovaries. Indeed, when
FGSCs isolated from adult minipig ovaries were infected by an EGFP lentivirus and injected into human ovarian cortex pieces, EGFP + oocytes were observed after 3 weeks in ovarian cortical xenografts. 148 In addition, FGSCs isolated from human cortical tissue (based on DDX4 expression) and transduced with a GFP-expression vector were shown to reform structures resembling follicles in culture with dispersed adult ovarian cells and to differentiate into oocytes when injected into human cortical tissue before xenotransplantation to nude mice. 149 In that study, the authors attributed FGSCs not being detected earlier by other teams to their smallness size (5-8 μm) and proportion (0.014±0.002%) of total ovarian cells. Ding et al also reported oocyte differentiation of FGSCs obtained from small cortical tissue fragments present in IVF patients' follicular aspirates. 150 However, the existence of FGSCs is not accepted universally. Even more controversy on the subject arose when Johnson et al published a study suggesting an extragonadal source from bone marrow and peripheral blood. 151 Eventually, with transplantation and parabiotic mouse models, the hypothesis that circulatory bone-marrow cells can generate ovulated oocytes both Table 2 Studies that attempted to restore male fertility using stem cells of mesenchymal origin in the steady state and after induced damage was discredited by several teams. 152, 153 Later, Lei and Spradling concluded that FGSCs could be dedifferentiated cells able to become germ cells under specific conditions as they did not detect these cells in mouse ovaries using a cell lineage-labeling system and demonstrated that the pool of primordial follicles generated during fetal life is sufficient to sustain adult oogenesis without a source of renewal. 154 Subsequently, other studies corroborated this hypothesis, as different teams were not able to detect FGSCs in mouse and human ovarian tissue using DDX4 lineage tracing, RT-PCR, or immunohistochemistry.
155-157
Reizel et al carried out an interesting study in which somatic mutations accumulated in microsatellites were used to reconstruct cell-lineage trees, which gave information on lineage relationships among different cell types.
Reconstructed cell trees showed that oocytes formed clusters distinct from bone-marrow cells in both young and adult mice, suggesting that the two cell types belong to separate lineages. A second interesting observation was that oocyte depth increased with mouse age. In other words, oocytes of older mice had undergone more mitotic divisions than those of younger mice, which could be explained by either depth-guided selection of oocytes for ovulation or postnatal renewal.
158
Use of SCs to treat ovarian reproductive failure
MSCs have been shown to act on the somatic compartment of the ovary, leading to reactivation and differentiation of "dormant" SCs ( Figure 4) . Notably, transplanted menstrual blood-derived endometrial MSCs (MenSCs) are able to migrate to the ovarian cortex and differentiate to granulosa cells, which improves FGSC renewal and restores fertility of sterilized mice. 159, 160 Other studies have demonstrated fertility restoration of sterilized mice or rats using SCs isolated from bone marrow, [161] [162] [163] [164] [165] [166] adipose tissue, 167, 168 amniotic fluid, 169 amnion, 170 and chorion (Table 3) . 171 Moreover, repeated bone marrow-derived MSCs (BMSCs) infusions through the tail vein not only postpone age-related ovarian failure in mice but improve the survival rate of offspring, suggesting a potential effect on egg quality. 172 With regard to humans, one team investigated transplantation of BMSCs into ovaries of 10 women diagnosed with premature ovarian failure and reported recovery of menstruation in two cases and one pregnancy with delivery of a healthy baby. 173 Even if promising, these results should be further confirmed and viewed with caution, since risks of transformation and tumorigenicity in MSC-based therapies are still debatable. 174 
Use of SCs to improve ovarian transplantation outcomes
Orthotopic autotransplantation of freeze-thawed pre-and postpubertal ovarian tissue already proved its efficacy, with more than 100 live births reported thus far 18, [175] [176] [177] [178] and a cumulative success rate of 57% (Figure 4 ).
179
Although these results are encouraging, an important loss of primordial follicles has been reported after transplantation. 180 To overcome this issue, several types of SCs have been used to improve graft oxygenation and follicle survival (Figure 4 ). Aware that MSCs play an important role in angiogenesis and stabilization of the blood-vessel network, Xia et al cotransplanted MSCs and ovarian tissue, both encapsulated in Matrigel and demonstrated that MSCs promoted neoangiogenesis and prevented loss of primordial follicles in grafts. 181 Angiogenin, which plays a role in angiogenesis and endothelial cell proliferation, has been further identified as a key MSC-secreted factor involved in follicle survival and revascularization of xenografted human ovarian tissue. 182 ASCs as another source of MSCs, with the advantage of easier access compared to BMSCs, have also been evaluated. After encapsulation of human ovarian tissue using a mix of ASCs and fibrin, higher graft oxygenation and vascular density with improved survival of primordial follicles was achieved compared to tissue transplantation only. 183 These results highlight the potency of MSCs in promoting graft revascularization.
Use of stem cells to improve follicle IVM
As autotransplantation has the potential risk of reintroducing cancer cells, succeeding in IVM of primordial follicles recovered from cryopreserved ovarian tissue is of paramount importance. 184 IVM of preantral and antral follicles isolated from thawed human ovarian tissue until a competent oocyte stage has been achieved, [185] [186] [187] although with lower efficiency for prepubertal tissue, 188 which could be explained by the higher proportion of abnormal follicles before puberty. 189 In an attempt to improve follicle IVM, MSCs have been exploited ( Figure  4) . Experiments conducted in vitro demonstrated that conditioned medium from human umbilical cord MSCs increased microvessel density and decreased apoptosis of in vitro cultured cortical tissue compared to serum-free Figure 4 ). Offspring were generated after in vitro fertilization of PGCLC-derived oocytes and embryo transfer to foster-mother mice, but epigenetic abnormalities were observed in half the generated eggs. The entire cycle of mouse oogenesis was later reproduced in vitro from ESCs and iPSCs, although a low success rate of full-term development was reported for ESC-derived embryos. 195 However, with regard to hESCs, development of structures resembling primary ovarian follicles was the most advanced stage of differentiation that could be reached. 196 
Conclusion
Development of methods to preserve and restore fertility of patients subjected to gonadotoxic therapies has become an urgent matter in these last few decades. On the male side, SSCs constitute a pool of SCs able to differentiate into spermatozoa. Restoration of male fertility with SSCs is still at the research stage, but experiments in animals suggest that autotransplantation of propagated and selected SSCs into the rete testis or autografting of ITT will be possible in future. In vitro differentiation of human spermatozoa with the aim of using in vitro matured sperm in ART can also be an option, especially when there is a risk of malignant contamination of ITT but needs further development with regard to efficiency of haploid-cell generation, completion of spermatogenesis and safety issues. The classical scheme that the female germ-cell pool is fixed after birth is under debate. Several studies lean toward the existence of SCs, but it cannot be excluded that FGSCs derive from dedifferentiated cells. Development of germ cells from other sources of SCs such as ESCs and iPSCs has also been proposed to restore fertility in both males and females, but the genetic stability of the cells and capacity to generate healthy offspring is uncertain. Finally, the use of MSCs to act against follicular loss in grafts or restore the damaged male or female somatic germ-cell environment has shown promising results, but long-term risks associated with MSC transplantation or culture still need to be evaluated.
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